Theme | Clinical evaluation – Software |
Target Audience | Manufacturers |
Products concerned | SaMD and Software as a part of a MD |
Regulatory reference | MDR (EU) 2017/745
Article 61 Article 2(51)
IVDR (EU) 2017/746 Article 56 Article 2(36)
|
Documents mentioned | GHTF/SG5/N7:2012
IMDRF/SaMD WG/N41FINAL:2017 MDCG 2019-11 IMDRF/GRRP WG/N47 FINAL:2018 GHTF/SG3/N18:2010 |
EN – This guidance provides a framework for the determination of the appropriate level of clinical evidence required for Medical Device Software (MDSW) to fulfil the requirements presented in the MDR and IVDR.
This document only applies to MDSW which are intended to be used, alone or in combination, with a medical purpose in accordance with the definition of a medical device in the MDR and IVDR.
There are three key elements to consider when compiling the clinical evidence for each MDSW :
- Determination of the validity of an MDSW output with a clinical condition or physiological state / scientific validity
- Technical Performance /Analytical Performance
- Clinical Performance.
Each of these elements is described in the guide according to the definition/determination/demonstration diagram.
Finally, the clinical evaluation/clinical performance evaluation process will be concluded with the final analysis and conclusions of the clinical evaluation (MD)/clinical performance evaluation (IVD) and a continuous update of this evaluation.